Kreslová, M.; Jehlička, P.; Sýkorová, A.; Rajdl, D.; Klásková, E.; Prokop, P.; Kaprálová, S.; Pavlíček, J.; Kaslová, R.; Palátová, A.;
et al. Circulating Serum Cystatin C as an Independent Risk Biomarker for Vascular Endothelial Dysfunction in Patients with COVID-19-Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Observational Study. Biomedicines 2022, 10, 2956.
https://doi.org/10.3390/biomedicines10112956
AMA Style
Kreslová M, Jehlička P, Sýkorová A, Rajdl D, Klásková E, Prokop P, Kaprálová S, Pavlíček J, Kaslová R, Palátová A,
et al. Circulating Serum Cystatin C as an Independent Risk Biomarker for Vascular Endothelial Dysfunction in Patients with COVID-19-Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Observational Study. Biomedicines. 2022; 10(11):2956.
https://doi.org/10.3390/biomedicines10112956
Chicago/Turabian Style
Kreslová, Marcela, Petr Jehlička, Aneta Sýkorová, Daniel Rajdl, Eva Klásková, Pavel Prokop, Sabina Kaprálová, Jan Pavlíček, Romana Kaslová, Alžběta Palátová,
and et al. 2022. "Circulating Serum Cystatin C as an Independent Risk Biomarker for Vascular Endothelial Dysfunction in Patients with COVID-19-Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Observational Study" Biomedicines 10, no. 11: 2956.
https://doi.org/10.3390/biomedicines10112956
APA Style
Kreslová, M., Jehlička, P., Sýkorová, A., Rajdl, D., Klásková, E., Prokop, P., Kaprálová, S., Pavlíček, J., Kaslová, R., Palátová, A., Mohylová, V., & Sýkora, J.
(2022). Circulating Serum Cystatin C as an Independent Risk Biomarker for Vascular Endothelial Dysfunction in Patients with COVID-19-Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Observational Study. Biomedicines, 10(11), 2956.
https://doi.org/10.3390/biomedicines10112956